{
    "clinical_study": {
        "@rank": "107432", 
        "arm_group": {
            "arm_group_label": "Subjects with and without Diabetes", 
            "arm_group_type": "Experimental", 
            "description": "All testing and lancing were performed by the study staff; Subjects with and without Diabetes did not perform any lancing or self-testing in this study.  Study Staff lanced the fingers of subjects and tested the blood samples using three Blood Glucose Monitoring Systems (BGMS):  Contour\u00ae NEXT LINK BGMS;  OneTouch\u00ae UltraLink\u00ae BGMS;  Nova Max Link\u00ae BGMS."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study was to evaluate the performance of a Bayer Blood Glucose\n      Monitoring System (BGMS) and two additional Blood Glucose Monitoring Systems (BGMS) from\n      other companies. All meter BG results were compared with plasma results obtained with a\n      reference laboratory glucose method (YSI Glucose Analyzer)."
        }, 
        "brief_title": "Evaluation of Blood Glucose Monitoring Systems", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": {
                        "@group_id": "B1", 
                        "description": "All testing and lancing were performed by the study staff; subjects with and without diabetes did not perform any lancing or self-testing in this study.  Study Staff tested the blood samples using three Blood Glucose Monitoring Systems (BGMS):  Contour\u00ae NEXT LINK BGMS;  OneTouch\u00ae UltraLink\u00ae BGMS;  Nova Max Link\u00ae BGMS.", 
                        "title": "Subjects With and Without Diabetes"
                    }
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "112"
                                        }
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@lower_limit": "19", 
                                            "@upper_limit": "87", 
                                            "@value": "59"
                                        }
                                    }
                                }
                            }, 
                            "dispersion": "Full Range", 
                            "param": "Median", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "67"
                                            }
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": {
                                                "@group_id": "B1", 
                                                "@value": "45"
                                            }
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": {
                                            "@group_id": "B1", 
                                            "@value": "112"
                                        }
                                    }, 
                                    "sub_title": "United States"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Using the overall Blood Glucose (BG) range (34 to 561 mg/dL according to YSI subject plasma results), the Mean Absolute Relative Differences (MARD) between the BGM System readings and the YSI plasma results (BG reference) were compared.  MARD is calculated from the sum of all /(BG meter)-(BG reference)//(BG reference) assessments, divided by the number of assessments, then multiplied by 100(%).  Each evaluable sample was tested on all 3 BGMS, thus the same number of BG test results was analyzed for each BGMS intervention.  Lower MARD value indicates smaller difference between meter value and the reference value.  Higher MARD value indicates larger difference between meter value and the reference value.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "All testing and lancing were performed by the study staff; subjects with and without diabetes did not perform any lancing or self-testing in this study.  Study Staff lanced the fingers of subjects and tested the blood samples using three Blood Glucose Monitoring Systems (BGMS):  Contour\u00ae NEXT LINK BGMS;  OneTouch\u00ae UltraLink\u00ae BGMS;  Nova Max Link\u00ae BGMS.", 
                                "title": "Subjects With and Without Diabetes"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "111"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "333"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of BG test results analyzed", 
                                    "units": "BG test results"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.33", 
                                                        "@value": "2.7"
                                                    }
                                                }, 
                                                "sub_title": "Contour\u00ae NEXT LINK BGMS"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.33", 
                                                        "@value": "10.8"
                                                    }
                                                }, 
                                                "sub_title": "OneTouch\u00ae UltraLink\u00ae BGMS"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.33", 
                                                        "@value": "6.4"
                                                    }
                                                }, 
                                                "sub_title": "Nova Max Link\u00ae BGMS"
                                            }
                                        ]
                                    }, 
                                    "description": "Using the overall Blood Glucose (BG) range (34 to 561 mg/dL according to YSI subject plasma results), the Mean Absolute Relative Differences (MARD) between the BGM System readings and the YSI plasma results (BG reference) were compared.  MARD is calculated from the sum of all /(BG meter)-(BG reference)//(BG reference) assessments, divided by the number of assessments, then multiplied by 100(%).  Each evaluable sample was tested on all 3 BGMS, thus the same number of BG test results was analyzed for each BGMS intervention.  Lower MARD value indicates smaller difference between meter value and the reference value.  Higher MARD value indicates larger difference between meter value and the reference value.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "MARD (Mean Absolute Relative Difference Between BGMS Results and Reference Method Results) Across the Overall Tested Glucose Range", 
                                    "units": "Percent Difference"
                                }
                            ]
                        }, 
                        "population": "Same number 333 (336-3) BG results possible for each BGMS.  Staff collected 3 capillary samples from each subject - total 336 samples.  Three samples from one subject were not analyzed.  Subject hematocrit (58.5) was above the study evaluable limit of 55.", 
                        "safety_issue": "No", 
                        "time_frame": "8 hours", 
                        "title": "MARD (Mean Absolute Relative Difference Between BGMS Results and Reference Method Results) Across the Overall Tested Glucose Range", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Using fresh and glycolyzed samples with YSI plasma Blood Glucose (BG) \u226480 mg/dL, the Mean Absolute Relative Differences (MARD) between the BGM System readings and the YSI subject plasma results (BG reference) were compared.  MARD is calculated from the sum of all /(BG meter)-(BG reference)//(BG reference) assessments, divided by the number of assessments, then multiplied by 100(%).  Each evaluable sample was tested on all 3 BGMS, thus the same number of BG test results was analyzed for each BGMS intervention.  Lower MARD value indicates smaller difference between meter value and the reference value.  Higher MARD value indicates larger difference between meter value and the reference value.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "All testing and lancing were performed by the study staff; subjects with and without diabetes did not perform any lancing or self-testing in this study.  Study Staff lanced the fingers of subjects and tested the blood samples using three Blood Glucose Monitoring Systems (BGMS):  Contour\u00ae NEXT LINK BGMS;  OneTouch\u00ae UltraLink\u00ae BGMS;  Nova Max Link\u00ae BGMS.", 
                                "title": "Subjects With and Without Diabetes"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "111"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "107"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of BG test results analyzed", 
                                    "units": "BG test results"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.69", 
                                                        "@value": "2.63"
                                                    }
                                                }, 
                                                "sub_title": "Contour\u00ae NEXT LINK BGMS"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.69", 
                                                        "@value": "14.92"
                                                    }
                                                }, 
                                                "sub_title": "OneTouch\u00ae UltraLink\u00ae BGMS"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.69", 
                                                        "@value": "8.81"
                                                    }
                                                }, 
                                                "sub_title": "Nova Max Link\u00ae BGMS"
                                            }
                                        ]
                                    }, 
                                    "description": "Using fresh and glycolyzed samples with YSI plasma Blood Glucose (BG) \u226480 mg/dL, the Mean Absolute Relative Differences (MARD) between the BGM System readings and the YSI subject plasma results (BG reference) were compared.  MARD is calculated from the sum of all /(BG meter)-(BG reference)//(BG reference) assessments, divided by the number of assessments, then multiplied by 100(%).  Each evaluable sample was tested on all 3 BGMS, thus the same number of BG test results was analyzed for each BGMS intervention.  Lower MARD value indicates smaller difference between meter value and the reference value.  Higher MARD value indicates larger difference between meter value and the reference value.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "MARD (Mean Absolute Relative Difference Between BGMS Results and Reference Method Results) in the Low Glucose Range (<=80 mg/dL)", 
                                    "units": "Percent Difference"
                                }
                            ]
                        }, 
                        "population": "Same number (107) of BG results was possible for each BGMS.  Staff collected 3 capillary samples from each subject (total 333), of which 107 samples  were less than or equal to 80 mg/dL.", 
                        "safety_issue": "No", 
                        "time_frame": "8 hours", 
                        "title": "MARD (Mean Absolute Relative Difference Between BGMS Results and Reference Method Results) in the Low Glucose Range (<=80 mg/dL)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Using samples with YSI plasma Blood Glucose (BG) >180 mg/dL, the Mean Absolute Relative Differences (MARD) between the BGM System readings and the YSI subject plasma results (BG reference) were compared.  MARD is calculated from the sum of all /(BG meter)-(BG reference)//(BG reference) assessments, divided by the number of assessments, then multiplied by 100(%).  Each evaluable sample was tested on all 3 BGMS, thus the same number of BG test results was analyzed for each BGMS intervention.  Lower MARD value indicates smaller difference between meter value and the reference value.  Higher MARD value indicates larger difference between meter value and the reference value.", 
                        "group_list": {
                            "group": {
                                "@group_id": "O1", 
                                "description": "All testing and lancing were performed by the study staff; subjects with and without diabetes did not perform any lancing or self-testing in this study.  Study Staff lanced the fingers of subjects and tested the blood samples using three Blood Glucose Monitoring Systems (BGMS):  Contour\u00ae NEXT LINK BGMS;  OneTouch\u00ae UltraLink\u00ae BGMS;  Nova Max Link\u00ae BGMS.", 
                                "title": "Subjects With and Without Diabetes"
                            }
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "111"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": {
                                                    "@group_id": "O1", 
                                                    "@value": "106"
                                                }
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of BG test results analyzed", 
                                    "units": "BG test results"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.76", 
                                                        "@value": "2.66"
                                                    }
                                                }, 
                                                "sub_title": "Contour\u00ae NEXT LINK BGMS"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.76", 
                                                        "@value": "8.76"
                                                    }
                                                }, 
                                                "sub_title": "OneTouch\u00ae UltraLink\u00ae BGMS"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.76", 
                                                        "@value": "4.52"
                                                    }
                                                }, 
                                                "sub_title": "Nova Max Link\u00ae BGMS"
                                            }
                                        ]
                                    }, 
                                    "description": "Using samples with YSI plasma Blood Glucose (BG) >180 mg/dL, the Mean Absolute Relative Differences (MARD) between the BGM System readings and the YSI subject plasma results (BG reference) were compared.  MARD is calculated from the sum of all /(BG meter)-(BG reference)//(BG reference) assessments, divided by the number of assessments, then multiplied by 100(%).  Each evaluable sample was tested on all 3 BGMS, thus the same number of BG test results was analyzed for each BGMS intervention.  Lower MARD value indicates smaller difference between meter value and the reference value.  Higher MARD value indicates larger difference between meter value and the reference value.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Mean", 
                                    "title": "MARD (Mean Absolute Relative Difference Between BGMS Results and Reference Method Results) in the High Glucose Range (>180 mg/dL)", 
                                    "units": "Percent Difference"
                                }
                            ]
                        }, 
                        "population": "Same number (106) of BG results was possible for each BGMS.  Staff collected 3 capillary samples from each subject (total 333), of which 106 samples  were greater than 180 mg/dL.", 
                        "safety_issue": "No", 
                        "time_frame": "8 hours", 
                        "title": "MARD (Mean Absolute Relative Difference Between BGMS Results and Reference Method Results) in the High Glucose Range (>180 mg/dL)", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": {
                        "@group_id": "P1", 
                        "description": "All testing and lancing were performed by the study staff; subjects with and without diabetes did not perform any lancing or self-testing in this study.  Study Staff tested the blood samples using three Blood Glucose Monitoring Systems (BGMS):  Contour\u00ae NEXT LINK BGMS;  OneTouch\u00ae UltraLink\u00ae BGMS;  Nova Max Link\u00ae BGMS.", 
                        "title": "Subjects With and Without Diabetes"
                    }
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "112", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "112", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "carmine.greene@bayer.com", 
                "name_or_title": "Carmine Greene", 
                "organization": "Bayer Healthcare, LLC,  Diabetes Care", 
                "phone": "574-257-3040"
            }, 
            "reported_events": {
                "group_list": {
                    "group": {
                        "@group_id": "E1", 
                        "description": "All testing and lancing were performed by the study staff; subjects with and without diabetes did not perform any lancing or self-testing in this study.  Study Staff lanced the fingers of subjects and tested the blood samples using three Blood Glucose Monitoring Systems (BGMS):  Contour\u00ae NEXT LINK BGMS;  OneTouch\u00ae UltraLink\u00ae BGMS;  Nova Max Link\u00ae BGMS.", 
                        "title": "Subjects With and Without Diabetes"
                    }
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "112"
                                        }, 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": {
                                            "@events": "2", 
                                            "@group_id": "E1", 
                                            "@subjects_affected": "2", 
                                            "@subjects_at_risk": "112"
                                        }, 
                                        "description": "Adverse event was mild, anticipated, non-device related.", 
                                        "sub_title": "hypoglycemia"
                                    }
                                }, 
                                "title": "Endocrine disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "frequency_threshold": "0"
                }
            }
        }, 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Diabetes", 
        "detailed_description": {
            "textblock": "The purpose of this study was to evaluate the performance of a Bayer Blood Glucose\n      Monitoring System (BGMS) and two additional Blood Glucose Monitoring Systems (BGMS) from\n      other companies. All meter BG results were compared with plasma results obtained with a\n      reference laboratory glucose method (YSI Glucose Analyzer). Performance of the three systems\n      was evaluated across the glucose range of the BGMSs using capillary blood. All testing and\n      lancing was performed by study staff and some samples were tested from subject fingertips.\n      Additionally, some blood samples were glycolyzed to lower the glucose concentration levels\n      and glucose solution was added to other samples to raise glucose concentration levels."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males and females, 18 years of age or older\n\n          -  Willing to complete all study procedures\n\n        Exclusion Criteria:\n\n          -  Blood Borne infections like hepatitis or HIV or infections such as  tuberculosis\n\n          -  Hemophilia or any other bleeding disorder\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "112", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 2, 2012", 
        "firstreceived_results_date": "September 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01699763", 
            "org_study_id": "CTD-2012-007-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Subjects with and without Diabetes", 
                "description": "Study staff performed Blood Glucose (BG) tests with capillary fingerstick blood collected from subjects with and without diabetes (up to 10% of subjects without diabetes were included). Performance of Contour\u00ae NEXT LINK BGMS was evaluated across the glucose range of the BGMSs.  All meter BG results were compared with capillary plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer).", 
                "intervention_name": "Contour\u00ae NEXT LINK BGMS", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Subjects with and without Diabetes", 
                "description": "Study staff performed Blood Glucose (BG) tests with capillary fingerstick blood collected from subjects with and without diabetes (up to 10% of subjects without diabetes were included). Performance of OneTouch\u00ae UltraLink\u00ae BGMS was evaluated across the glucose range of the BGMSs.  All meter BG results were compared with capillary plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer).", 
                "intervention_name": "OneTouch\u00ae UltraLink\u00ae BGMS", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Subjects with and without Diabetes", 
                "description": "Study staff performed Blood Glucose (BG) tests with capillary fingerstick blood collected from subjects with and without diabetes (up to 10% of subjects without diabetes were included). Performance of Nova Max Link\u00ae BGMS was evaluated across the glucose range of the BGMSs.  All meter BG results were compared with capillary plasma results obtained with a reference laboratory glucose method (YSI Glucose Analyzer).", 
                "intervention_name": "Nova Max Link\u00ae BGMS", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Mishawaka", 
                    "country": "United States", 
                    "state": "Indiana", 
                    "zip": "46544"
                }, 
                "name": "Bayer HealthCare LLC, Diabetes Care"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of Blood Glucose Meter Systems - Contour\u00ae NEXT LINK Study", 
        "overall_official": {
            "affiliation": "Bayer HealthCare, Diabetes Care", 
            "last_name": "David Simmons, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Using the overall Blood Glucose (BG) range (34 to 561 mg/dL according to YSI subject plasma results), the Mean Absolute Relative Differences (MARD) between the BGM System readings and the YSI plasma results (BG reference) were compared.  MARD is calculated from the sum of all /(BG meter)-(BG reference)//(BG reference) assessments, divided by the number of assessments, then multiplied by 100(%).  Each evaluable sample was tested on all 3 BGMS, thus the same number of BG test results was analyzed for each BGMS intervention.  Lower MARD value indicates smaller difference between meter value and the reference value.  Higher MARD value indicates larger difference between meter value and the reference value.", 
            "measure": "MARD (Mean Absolute Relative Difference Between BGMS Results and Reference Method Results) Across the Overall Tested Glucose Range", 
            "safety_issue": "No", 
            "time_frame": "8 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01699763"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Using fresh and glycolyzed samples with YSI plasma Blood Glucose (BG) \u226480 mg/dL, the Mean Absolute Relative Differences (MARD) between the BGM System readings and the YSI subject plasma results (BG reference) were compared.  MARD is calculated from the sum of all /(BG meter)-(BG reference)//(BG reference) assessments, divided by the number of assessments, then multiplied by 100(%).  Each evaluable sample was tested on all 3 BGMS, thus the same number of BG test results was analyzed for each BGMS intervention.  Lower MARD value indicates smaller difference between meter value and the reference value.  Higher MARD value indicates larger difference between meter value and the reference value.", 
                "measure": "MARD (Mean Absolute Relative Difference Between BGMS Results and Reference Method Results) in the Low Glucose Range (<=80 mg/dL)", 
                "safety_issue": "No", 
                "time_frame": "8 hours"
            }, 
            {
                "description": "Using samples with YSI plasma Blood Glucose (BG) >180 mg/dL, the Mean Absolute Relative Differences (MARD) between the BGM System readings and the YSI subject plasma results (BG reference) were compared.  MARD is calculated from the sum of all /(BG meter)-(BG reference)//(BG reference) assessments, divided by the number of assessments, then multiplied by 100(%).  Each evaluable sample was tested on all 3 BGMS, thus the same number of BG test results was analyzed for each BGMS intervention.  Lower MARD value indicates smaller difference between meter value and the reference value.  Higher MARD value indicates larger difference between meter value and the reference value.", 
                "measure": "MARD (Mean Absolute Relative Difference Between BGMS Results and Reference Method Results) in the High Glucose Range (>180 mg/dL)", 
                "safety_issue": "No", 
                "time_frame": "8 hours"
            }
        ], 
        "source": "Bayer HealthCare, Diabetes Care", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bayer HealthCare, Diabetes Care", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}